TherapeuticsMD
TXMD
TXMD
36 hedge funds and large institutions have $9.02M invested in TherapeuticsMD in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
28% less capital invested
Capital invested by funds: $12.5M → $9.02M (-$3.47M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
36
Holding in Top 10
–
Calls
$312K
Puts
$79K
Top Buyers
| 1 | +$30.7K | |
| 2 | +$24.5K | |
| 3 | +$9.08K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.79K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.95K |
Top Sellers
| 1 | -$217K | |
| 2 | -$24K | |
| 3 | -$9.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.06K |
| 5 |
BlackRock
New York
|
-$1.88K |